Ipigrix (Ipidacrine Hydrochloride)

Ipidacrine Hydrochloride reversibly blocks acetylcholinesterase, the enzyme that degrades acetylcholine. By inhibiting this enzyme, the drug raises acetylcholine levels in the brain, enhancing cholinergic neurotransmission that supports learning, memory formation, and other cognitive processes.

The appropriate dose of Ipigrix is determined by the prescribing clinician based on the patient’s condition, age, renal and hepatic function, and response to therapy. No fixed regimen is provided here; dosing must follow the prescriber’s instructions.

Safety data for Ipidacrine Hydrochloride in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Ipigrix, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ipigrix (Ipidacrine) is a reversible acetylcholinesterase inhibitor similar in class to donepezil or rivastigmine, but it has a distinct chemical structure and may differ in potency, side‑effect profile, and drug‑interaction potential. Choice of agent depends on individual patient factors and physician judgment.

Ipigrix should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Ipigrix is taken orally, usually with water. The tablet (or oral formulation) should be swallowed whole and not chewed or crushed unless otherwise directed by a healthcare professional.

Serious adverse events include hepatotoxicity, significant cardiac arrhythmias such as severe bradycardia, and severe allergic reactions including anaphylaxis. Patients should seek immediate medical attention if they experience signs of liver dysfunction, irregular heartbeat, or any severe hypersensitivity symptoms.

Ipigrix is contraindicated in patients with known hypersensitivity to Ipidacrine Hydrochloride or any excipients, those with severe hepatic impairment, and individuals taking other potent acetylcholinesterase inhibitors without medical supervision. Pregnant or nursing women should only use it when clearly indicated by a physician.